Table 2.

Immunosuppressive or Immunomodulatory Therapeutic Regimens Justifying PCP Prophylaxis (n = 362)

Therapeutic Regimen	No. of Respondents (%)a
High-dose corticosteroids (≥20 mg daily for ≥3 mo)	316 (87)
High-dose corticosteroids PLUS nonbiologic DMARDs (methotrexate)	249 (69)
High-dose corticosteroids PLUS biologic DMARDs (TNFi, rituximab)	280 (77)
High-dose corticosteroids PLUS cytotoxic agents (cyclophosphamide)	281 (78)
Nonbiologic DMARDs	8 (2)
Biologic DMARDs	53 (15)
Nonbiologic DMARDs PLUS biologic DMARDs	43 (12)
Intravenous immunoglobulin	0
None	4 (1)
Not sure	18 (5)

Abbreviations: DMARDs, disease-modifying antirheumatic drugs; PCP, Pneumocystis pneumonia; TNFi, tumor necrosis factor inhibitor.

^aRespondents could select all that apply so totals may exceed 100%.